Master in International Translational Medicine
This impactful, career-transforming program is designed for life science professionals who wish to apply their expertise to addressing unmet medical needs, while leveraging the opportunities created by the development of innovative solutions.
The program is structured to accommodate ongoing professional commitments, including employment and other professional development activities, as it is offered on apart-time basis. It follows a hybrid format (online and in-person sessions) and covers the full spectrum of translational medicine.
Our partnership with the Eureka Institute for Translational Medicine provides you with skills you can apply immediately in your work, along with access to a global network of professionals who will support your growth beyond the program.
DETAILS
YEARS
2
ECTS
60
LANGUAGE
English
ADMISSION
Evaluation of qualifications
ADMISSION DATES
The call for applications will close on September 30, 2026
Le iscrizioni sono aperte
Le iscrizioni sono aperte
Are you interested in the Master?
Why choose the Master in International Translational Medicine at UniSR?
A concrete bridge between research and clinical practice
The Master’s program trains professionals capable of transforming scientific discoveries into clinical solutions with a real impact on patient health. The curriculum addresses the entire translational medicine pathway, from preclinical research to clinical development, tackling the challenges of therapeutic innovation and unmet clinical needs.
An innovative and international educational approach
The program stands out for its hands-on teaching approach, integrating lectures, intensive modules, practical activities, project work, workshops, and simulations. The collaboration with the Eureka Institute for Translational Medicine and the involvement of international faculty and professionals ensure an interdisciplinary education strongly oriented toward real-world experience.
A network of excellence for professional development
Through an international network of researchers, clinicians, industry experts, and stakeholders, the Master offers concrete opportunities for networking, mentoring, and professional growth. The skills acquired open career pathways in clinical research, the biotech and pharmaceutical industries, and in global healthcare system development and innovation.
Overview
The Master in International Translational Medicine is a two-year, part-time, hybrid-learning program designed for professionals who aspire to translate scientific discoveries into real world tangible patient-centered solutions.
You should take our Master if you want to advance and transform your professional evolution path while contributing meaningfully to improving patients' lives, developing society and advancing science. You will develop your leadership, communication, and problem‑solving abilities while familiarizing yourself with every aspect of translational medicine. You will be nested and be active part of an international network which covers the entire gradient of translational medicine.
The Master in International Translational Medicine employs state-of-art teaching and experiential technologies which blend online and in-person experiences into a unique, engaging and evidence-based approach.
The program integrates participants into an international translational medicine ecosystem that is actively shaping the future of healthcare innovation. It equips you with the strategic, operational, and interpersonal competencies required to successfully navigate the full translational medicine pathway—from discovery to clinical and real-world impact.
Curriculum and learning outcomes
The Master in International Translational Medicine includes lectures and classroom-based teaching, sometimes online, sometimes delivered in person, but always engaging and evidence-based.
The program stands out for its innovative and interdisciplinary educational approach, characterized by a blended, hands-on learning model that combines lectures, intensive modules, practical activities, project work, workshops, and simulations.
The curriculum is stackable and modular, allowing participants to build competencies progressively or focus on specific areas of translational medicine.
Each module carries 2.5 ECTS and can be taken individually and in any order, with a tuition fee of €12,000 per module. Each can be taken individually.
The program is organized into the following thematic modules:
Thematic modules
From unmet need to cure
Key Concepts: Translational Medicine, stakeholders, druggability, intellectual property
This module introduces the full translational continuum, starting from unmet medical needs and moving toward effective therapies. Participants explore how scientific discovery, patient needs, regulatory pathways, and intellectual property considerations converge to shape viable translational strategies.
Through real-world examples, the course highlights how decisions on druggability, target selection, and IP protection influence whether promising discoveries can ultimately reach patients.
From need to target
Key Concepts: Immunology, genetics, epigenetics, bioinformatics, omics-scale data, data science, AI, experimental design
This module focuses on the scientific foundations of target discovery and validation. Participants learn how modern immunology, genetics, epigenetics, and omics technologies are integrated with data science and AI to identify robust and actionable targets.
Emphasisis placed on experimental design, data interpretation, and hypothesis generation, equipping participants to critically evaluate evidence and design translationally relevant research programs.
Clinical development
Key Concepts: Clinical trials, research ethics, scientific writing, post-marketing surveillance
This module covers the clinical phase of translational medicine, from first-in-human studies to post-marketing surveillance. Participants gain insight into clinical trial design, ethical considerations, regulatory requirements, and the generation of high-quality clinical evidence.
The module also strengthens scientific writing skills, enabling participants to communicate results clearly and responsibly to regulators, journals, and the broader scientific and non-scientific community.
Understanding the importance of harmonizing stakeholders’interests to advance the field
Key Concepts: Risk analysis from multiple perspectives, mitigation strategies
Translational Medicine moves discoveries from the lab toward real-world impact: This but the journey is shaped by a diverse set of stakeholders, each with their own priorities, incentives, and risks. This module gives participants a deep, practical understanding of this landscape and equips them with the skills to collaborate, communicate, and make informed decisions across the entire continuum.
Entrepreneurship
Key Concepts: Business models, startups, financing, funding, stakeholder-centric innovation, venture pitching
This module introduces participants to the entrepreneurial dimension of translational medicine. It explores how scientific innovation is transformed into sustainable ventures through appropriate business models, funding strategies, and stakeholder-centric approaches.
Participants learn how to engage investors, industry partners, and other stakeholders, and how to develop and deliver effective venture and industry pitches grounded intranslational value and societal impact.
Study plan
This course strengthens the analytical, interpersonal, and communication skills required to navigate the multi-stakeholder environment of Translational Medicine. Participants gain a holistic understanding of the innovation pathway and learn how to translate scientific discoveries into viable development strategies. Organisations benefit from employees who think more strategically, communicate more effectively, and contribute more confidently to the advancement of promising discoveries.
Through interactive sessions, case discussions, and direct engagement with stakeholders, participants learn how scientific, clinical, regulatory, and commercial perspectives intersect. The course also builds advanced communication capabilities, enabling participants to present complex translational pathways through clear data visualizations and compelling narratives tailored to different audiences.
Before each session, participants receive preparatory reading materials that lay the groundwork for meaningful engagement throughout the module.
The teaching activities are complemented by an internship and project work (30 ECTS) and a final examination (15 ECTS) in the form of an individual thesis.
The modular structure enables participants to tailor their learning path to their professional goals while maintaining academic rigor and real-world relevance.
What you will learn
This course helps participants develop the mindset and tools needed to operate effectively in the Translational Medicine ecosystem. You will learn to:
- Identify and understand the roles, motivations, and risk profiles of key stakeholders.
- Recognize scientific, operational, regulatory, and commercial risks early — and explore strategies to mitigate them.
- Engage more effectively with clinicians, patients, regulators, payers, and industry partners.
- Communicate complex scientific and translational concepts using clear, audience-appropriate visualizations.
- Build persuasive, data-driven narratives that support decision-making and cross-functional collaboration.
- Contribute more confidently to multidisciplinary teams working on early-stage innovation.
What this course enables you to do
After completing the course, participants will be able to:
- Anticipate stakeholder concerns and address them proactively.
- Present research and innovation concepts in ways that resonate with scientific and non-scientific audiences.
- Navigate cross-functional environments with greater clarity and confidence.
- Position scientific work within broader clinical, regulatory, and commercial contexts.
- Reduce uncertainty in early-stage projects through structured analysis and communication.
What employers gain
For leaders and managers in pharma, biotech, government, hospitals and other healthcare organisations, this course delivers clear strategic value.
Employees return with:
- A deeper understanding of how scientific decisions intersect with regulatory, clinical, and commercial realities.
- Improved ability to identify and de-risk translational bottlenecks early, saving time and resources.
- Stronger cross-functional communication skills that support smoother collaboration across RCD, clinical, regulatory, and commercial teams.
- Enhanced capability to articulate the value, feasibility, and risks of scientific concepts to internal and external stakeholders.
- A stakeholder-aware mindset that supports strategic decision-making and portfolio progression.
Program structure and practicalities
The Master in International Translational Medicine is a two-year, part-time, executive-style stackable program, designed for professionals in full-time employment.
In-person activities take place at both the Vita-Salute San Raffaele University in Milan and the Eureka Institute for Translational Medicine, fostering direct interaction with international faculty, clinicians, researchers, and professionals.
• The training activities will take place over a 24-month period, starting in November 2026.
• The Master’s program is organized into 6 intensive modules, each lasting from 5 days to several weeks, delivered in a blended format (in-person and online lectures).
• Practical sessions and networking opportunities will be held in person at the campuses of the two partner institutions: UniSR in Milan and the Eureka Institute For Transaltional Medicine in Syracuse.
• Attendance is mandatory for all educational and practical activities.
• The training also includes internships, project work, and a final thesis, enabling participants to apply the acquired skills in real-world contexts.
• The final assessment consists of writing and presenting a clinical-experimental or project-based thesis, to be submitted to the Academic Committee.
• Regular meetings with the Program Directors and tutors are scheduled to monitor ongoing learning progress.
• The Master’s degree comprises 60 ECTS credits: 15 ECTS from lectures and teaching activities, 30 ECTS from internship and project work, and 15 ECTS from the final examination, completed.
Our partner: The Eureka Institute for Translational Medicine
Founded in 2008, the Eureka Institute for Translational Medicine was created to accelerate biomedical innovation with real impact on patients and society. Beyond education, Eureka functions as a global hub that connects clinicians, scientists, entrepreneurs, industry leaders, regulators, and investors across continents, enabling collaborations that extend far beyond the classroom.
A global network that generates real-world outcomes
The defining strength of the Eureka Institute lies in its international network. Participants are immersed in a living ecosystem where ideas, expertise, and opportunities circulate continuously. This environment is designed not only to share knowledge, but to catalyze action—facilitating the creation of startups, the launch of multinational research initiatives, the development of innovative clinical programs, and long-term cross-institutional collaborations.
Rather than focusing solely on didactic training, Eureka emphasizes experiential engagement: working side-by-side with global leaders on real challenges intranslational medicine, innovation, and healthcare transformation. Many collaborations initiated within the Eureka network continue well beyond the program, evolving into funded projects, companies, or enduring professional partnerships.
Access to an unparalleled international community
As a Master in International Translational Medicine student, you gain entry into a highly selective, global community that offers opportunities unavailable in traditional academic programs. Through direct interaction with Eureka faculty, partners, and alumni worldwide, you become part of a network that supports mentorship, career mobility, entrepreneurial ventures, and international leadership roles—often producing tangible outcomes that reshape professional trajectories.
Course directors
-
Chiara Bonini
Full Professor of Hematology at Vita-Salute San Raffaele University and Vice Director of Immunology Research at San Raffaele Scientific Institute. A pioneer in cellular and gene therapy, she has led groundbreaking clinical trials on engineered T cells for cancer and immune disorders. Her work bridges cutting-edge science and patient care, shaping the future of immunotherapy worldwide. With international experience from institutions like Fred Hutchinson and Memorial Sloan Kettering, she is a recognized leader in translational research. Passionate about innovation, Bonini’s research continues to redefine therapeutic strategies against hematologic malignancies and beyond.
-
Salvatore Albani
Professor at Duke-NUS Medical School in Singapore and Director of the Translational Immunology Institute, he is an expert in the analysis and manipulation of human immunity to improve health. He has developed an advanced technological platform that integrates cytometry, single-cell RNA sequencing, and artificial intelligence to identify new therapeutic targets. Among his main contributions are the AI-driven architecture of the healthy immunome, CAR Tregs for autoimmunity, and a novel immunotherapy for rheumatoid arthritis. He is the author of over 100 patents and high-impact publications, with a strong entrepreneurial track record. He is also President of the Eureka Institute, dedicated to the training and promotion of translational medicine.
The full faculty list will be announced shortly.
Are you interested in this degree course?
Fill out the form with your email: we will send you the information you need to know for the entrance test. No spam, we promise!
Admissions
Admission requirements
-
Lorem Ipsum
The Master’s programme is designed for the full spectrum of translational medicine practitioners. It is intended for professionals and graduates who play — or aspire to play —an active role at any stage of the translational medicine continuum, from scientific discovery to real-world implementation and impact on patient care.
The programme deliberately embraces the diversity of roles that define modern translational medicine, recognizing that progress in this field requires the coordinated contribution of scientific, clinical, regulatory, legal, entrepreneurial, financial, and industrial expertise.
We welcome applications from a broad and interdisciplinary range of professional backgrounds, including but not limited to:
- Professionals with training or experience in biomedical, scientific, healthcare, or life science–related fields;
- Clinicians, researchers, scientists, and healthcare professionals involved in clinical research, therapeutic innovation, or healthcare development;
- Professionals from adjacent or complementary fields such as biotechnology, pharmaceutical development, medical devices, digital health, innovation, policy, and regulatory environments;
- Legal professionals, including regulatory and healthcare lawyers, intellectual property experts, and professionals involved in compliance and governance;
- Venture capital professionals, investors, financiers, and fund managers engaged in life sciences, healthcare innovation, or biomedical entrepreneurship;
- Executives, managers, and leaders from industry, ranging from large pharmaceutical companies to small and medium-sized enterprises (SMEs) operating in the translational medicine ecosystem;
- Individuals seeking to transition from academia or healthcare into industry, innovation, leadership, regulatory, or entrepreneurial pathways.
Eligibility
Applicants should hold at least a Bachelor’s degree or equivalent qualification and demonstrate a clear professional interest, involvement, or strategic role within translational medicine, healthcare, life sciences, or closely related sectors.
The programme values diversity of professional perspectives as a core educational and strategic asset. It is intended for candidates motivated to acquire the interdisciplinary knowledge, skills, and collaborative mindset necessary to operate effectively across the breadth and depth of the translational medicine field.
Documents to attach
The documents to be attached to the application are as follows:
-
Autocertificazione o certificato di Laurea triennale con l’indicazione del voto;
-
Autocertificazione o certificato di Laurea magistrale (se conseguita);
-
Curriculum vitae formativo professionale firmato;
-
Copia di un documento di identità personale in corso di validità;
-
Eventuali altri titoli.
How to apply
2026/2027 Admissions to the II level Master in International Translational Medicine are open!
The deadline to apply, through the online application portal PICA, is September 30th 2026 (11:59 PM, CET) (Master Code: 2026-01)
In order to complete your application, please prepare the following documents in PDF format (max 30Mbyte) to be uploaded:
-
Passport
-
Degree along with final grade and legalized translation
-
Final Degree Thesis (index, abstract, title)
-
Specialization Degree and PHD along with final thesis (if in possession of)
-
Curriculum Vitae and Motivation Letter
-
Scientific Pubblications
International Candidates are additionally requested to provide:
-
Legalized translation of the Degree Diploma
-
Declaration of Value (to be issued by the Italian Embassy/Consulate where the degree was obtained) or the Statements of Comparability and Verification, issued by CIMEA.
Should you not be able to complete your application in one session, you can access the admission portal several times in order to do so.
Once the application is submitted, you will receive a confimation email/integration request from UniSR Master Office.
The Title evaluation and the interview will take place once admissions will be closed, starting from September 30th, 2026.
A professional medical insurance will be requested upon enrollment.
Request information
Fill in the form with your email address
We will send you all the information you need to submit your application.
No spam, we promise! 🤞
For your future, choose the best.
Vita-Salute San Raffaele University is a reference point for excellent university education, being one of the most highly rated universities in our country.
1st
20th
1st
Censis, Università non statali ed. 2024-25